BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22461193)

  • 1. Expression of A20 is reduced in pancreatic cancer tissues.
    Wang Q; Yuan L; Liu Z; Yin J; Jiang X; Lu J
    J Mol Histol; 2012 Jun; 43(3):319-25. PubMed ID: 22461193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression.
    Chen H; Hu L; Luo Z; Zhang J; Zhang C; Qiu B; Dong L; Tan Y; Ding J; Tang S; Shen F; Li Z; Wang H
    Mol Cancer; 2015 Nov; 14():186. PubMed ID: 26538215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
    Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma.
    Costello LC; Levy BA; Desouki MM; Zou J; Bagasra O; Johnson LA; Hanna N; Franklin RB
    Cancer Biol Ther; 2011 Aug; 12(4):297-303. PubMed ID: 21613827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of tumor necrosis factor-alpha-induced protein 8 in pancreas tissues and its correlation with epithelial growth factor receptor levels.
    Liu K; Qin CK; Wang ZY; Liu SX; Cui XP; Zhang DY
    Asian Pac J Cancer Prev; 2012; 13(3):847-50. PubMed ID: 22631659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of A20 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Li D; Wang L; Fan Y; Song L; Guo C; Zhu F; Zhang L; Shi Y
    J Clin Immunol; 2012 Dec; 32(6):1287-91. PubMed ID: 22898832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A20 is overexpressed in glioma cells and may serve as a potential therapeutic target.
    Guo Q; Dong H; Liu X; Wang C; Liu N; Zhang J; Li B; Cao W; Ding T; Yang Z; Zhang X
    Expert Opin Ther Targets; 2009 Jul; 13(7):733-41. PubMed ID: 19492975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].
    Liang ZY; Wang WZ; Gao J; Wu SF; Zeng X; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):102-6. PubMed ID: 17493384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma.
    Huang C; Huang R; Chang W; Jiang T; Huang K; Cao J; Sun X; Qiu Z
    Neoplasma; 2012; 59(1):52-61. PubMed ID: 22082308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
    Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z
    World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
    Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
    Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased A20 mRNA and protein expression in peripheral blood mononuclear cells in patients with type 2 diabetes and latent autoimmune diabetes in adults.
    Cheng L; Zhang D; Jiang Y; Deng W; Wu Q; Jiang X; Chen B
    Diabetes Res Clin Pract; 2014 Dec; 106(3):611-6. PubMed ID: 25451900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder polypoid cystitis-derived A20 associates with tumorigenesis.
    Wang M; Li S
    Cell Biochem Biophys; 2013 Nov; 67(2):669-73. PubMed ID: 23471665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma.
    Mann CD; Bastianpillai C; Neal CP; Masood MM; Jones DJ; Teichert F; Singh R; Karpova E; Berry DP; Manson MM
    PLoS One; 2012; 7(12):e51119. PubMed ID: 23226563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of A20 gene polymorphisms and clinical significance in patients with rheumatoid arthritis.
    Zhu L; Wang L; Wang X; Zhou L; Liao Z; Xu L; Wu H; Ren J; Li Z; Yang L; Chen S; Li B; Wu X; Zhou Y; Li Y
    J Transl Med; 2015 Jul; 13():215. PubMed ID: 26143186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical significance of FRAT1 and ABCG2 expression in pancreatic ductal adenocarcinoma.
    Yuan Y; Yang Z; Miao X; Li D; Liu Z; Zou Q
    Tumour Biol; 2015 Dec; 36(12):9961-8. PubMed ID: 26178481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1.
    Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B
    Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.